Literature DB >> 4857860

Evaluation of rifamycin SV and rifampin kinetics in lactating ewes.

G Ziv, F G Sulman.   

Abstract

Serum and milk concentrations of rifamycin SV and rifampin were determined in lactating ewes after a single intravenous injection, and pharmacokinetic parameters were evaluated by the two-compartment open-system model. Rifampin was distributed throughout a greater volume than rifamycin SV and was eliminated more slowly from the body. The concentrations of the two drugs, both lipophilic weak acids, in milk after intravenous or intramuscular injection were lower than in serum, but rifampin was detected in milk sooner and for longer periods than rifamycin SV. Under constant serum drug concentrations, the observed milk/serum ultrafiltrate concentrations ratios (0.19 to 0.29 for rifamycin SV, and 0.90 to 1.28 for rifampin) were close to the calculated ratios derived from the pH-pK passive diffusion concept.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4857860      PMCID: PMC428935          DOI: 10.1128/AAC.5.2.139

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors:  S Riegelman; J Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

2.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

3.  Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.

Authors:  S Furesz; R Scotti; R Pallanza; E Mapelli
Journal:  Arzneimittelforschung       Date:  1967-05

Review 4.  Rifamycin SV. A review.

Authors:  N Bergamini; G Fowst
Journal:  Arzneimittelforschung       Date:  1965-08

5.  Effect of mode of administration on drug distribution in a two-compartment open system.

Authors:  M Gibaldi
Journal:  J Pharm Sci       Date:  1969-03       Impact factor: 3.534

6.  The use of rifamycin SV in the treatment of bovine mastitis.

Authors:  G Redaelli; S Nani; G Ruffo; A Socci; L Guallini
Journal:  Vet Rec       Date:  1971-03-20       Impact factor: 2.695

7.  Pharmacokinetic evaluation of penicillin and cephalosporin derivatives in serum and milk of lactating cows and ewes.

Authors:  G Ziv; J Shani; F G Sulman
Journal:  Am J Vet Res       Date:  1973-12       Impact factor: 1.156

8.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

9.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

10.  Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.

Authors:  J G Wagner; J I Northam
Journal:  J Pharm Sci       Date:  1967-04       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.